Navigation Links
Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action
Date:2/25/2011

CHAPEL HILL, N.C., Feb. 25, 2011 /PRNewswire/ -- Deston Therapeutics LLC ("Deston") announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution ("Auralgan") by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.

"Despite the recent actions by the government, we believe that Auralgan is still a safe and effective treatment for ear pain and inflammation," said David Preston RPh, CEO of Deston.  "Auralgan has a long history of safe marketing and use, the medical literature supports the effectiveness of this product, and the side effects associated with this product are well-known.  The current situation is a result of a misunderstanding between FDA and Deston and not of a product safety concern."

On February 14, 2011, the Federal Government initiated an action in United States District Court of the Western District of Kentucky to condemn shipments of Auralgan located at Deston's distributor asserting that this drug product was a "new drug" that had not received prior approval from the Food and Drug Administration ("FDA") before it was sold.  

"While the government has seized shipments of Auralgan, the current complaint is not directed against Deston, its suppliers, or its distributors," said Edward John Allera, who is Deston's legal counsel, a partner at Buchanan Ingersoll & Rooney PC, a former FDA attorney and an expert in this area. "Instead, the current complaint focuses only on those units of Auralgan held by one distributor."

The central issue in this proceeding is the precise legal status of Auralgan as a "new drug" or an "old drug."  In its pleadings, the Federal Government asserts that Auralgan is a "new drug", but these allegations did not provide any new information regarding the safety or efficacy of Auralgan.  According to Mr. Allera, "The government has not provided any new evidence in i
'/>"/>

SOURCE Deston Therapeutics LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
(Date:12/24/2014)... Dec. 23, 2014  Medical Science Liaisons play a ... link between the medical device industry and key stakeholders, ... the coming years as the device industry relies on ... to research by benchmarking firm, Best Practices, LLC, one ... important edge is by harnessing new technology to enable ...
(Date:12/22/2014)... VIEJO, Calif. , Dec. 22, 2014 ... into expanded corporate offices in Aliso Viejo ... announced that due to the tremendous growth and worldwide ... needed. Sales of patented SnoreRx, the anti snore cure ... offices. He said, "We are now in 23 ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Role of Medical Science Liaisons Evolving in Medical Device Sector 2
... DIEGO , March 22 Naviscan announced ... Services, will be offering mobile Positron Emission Mammography (PEM) ...  Alliance Imaging will be providing turnkey service which includes ... technologist to perform the scan and the necessary radiopharmaceutical, ...
... provisions included in health care reform legislation passed by the U.S. House of Representatives will improve community pharmacists, ability to improve patient outcomes and reduce costs, the National Community Pharmacists ... ... ... ...
Cached Medicine Technology:Alliance Imaging Offers Mobile Positron Emission Mammography (PEM) Imaging to its Florida Customers 2Alliance Imaging Offers Mobile Positron Emission Mammography (PEM) Imaging to its Florida Customers 3Alliance Imaging Offers Mobile Positron Emission Mammography (PEM) Imaging to its Florida Customers 4NCPA Commends Pharmacy Provisions in House-Passed Health Care Reform Bill 2NCPA Commends Pharmacy Provisions in House-Passed Health Care Reform Bill 3
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) – ... the current treatment landscape, unmet needs, current pipeline ... Stivarga is a drug which is used in ... Ingelheim is developing nintedanib (BIBF-1120), an orally available ... in the US, Europe, and Japan. The drug ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Plugin creators ... ProFire 5k. A fully customizable business presentation tool made ... “Adding the ProFire 5k business tool, users can now ... Austin, CEO of Pixel Film Studios. “ProFire 5k gives ... style to add professionalism to a presentation” , Pixel ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... Mo., Dec. 17 In an effort to,help ... Corporation and the United Nations Environment Programme,s North,American ... World,Environment Day partnership and launched the International Children,s,Painting ... International Children,s Painting Competition (ICPC) invites,elementary and middle ...
... SAN FRANCISCO, Dec. 17 AmeriMark Direct,a direct ... today announced that it has acquired New Jersey-based,direct-marketer ... catalog businesses currently generate combined sales in,excess of ... six million,active customers over 55 years of age, ...
... have shown that a commonly available antibiotic can improve ... and may also generate significant health care savings. , ... of Respiratory and Critical Care Medicine, a top international ... therapy in conjunction with current asthma treatment. , The ...
... are able to adhere to a regular program of moderate ... and women suggests. Led by corresponding author Roger Fielding, ... on Aging (USDA HNRCA) at Tufts University, the authors observed ... ability to adhere to the physical activity regimen. , ...
... for Biotechnology and Genomic Medicine has been selected to isolate ... involved in a worldwide study of the causes of type ... mammoth study that will eventually follow 8,000 at-risk babies from ... every three months as they go. , The TEDDY ...
... 17 STAAR Surgical,Company (Nasdaq: STAA ), ... ophthalmic products, today announced that it has,borrowed $5.0 ... note to fund its purchase of the remaining ... was formed by STAAR, Canon Inc. and,Canon Marketing ...
Cached Medicine News:Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools 2Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools 3Health News:New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools 4Health News:AmeriMark Direct Acquires Dr. Leonard's Healthcare 2Health News:AmeriMark Direct Acquires Dr. Leonard's Healthcare 3Health News:Antibiotic treatment targets difficult asthma 2Health News:Elderly at risk for physical disabilities exercise, improve physical function 2Health News:MCG selected as RNA laboratory for worldwide diabetes study 2Health News:STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture 2Health News:STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture 3Health News:STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture 4
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left....
Double-ended. Designated most popular model or size....
Medicine Products: